About Sumitomo Pharma
Our Mission is "To contribute broadly to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide." By channeling efforts into the research and development of new drugs, Sumitomo Pharma aims to realize this Mission and provide innovative and useful pharmaceuticals and healthcare solutions to people in Japan and around the world.
Philosophy
Philosophy
(The significance of our existence, commitment and duty to society)
To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide
(Values that all executives and employees should share)
- Patient First
- Always with Integrity
- One Diverse Team
(The code of conduct to be observed in daily work by all executives and employees)
- 1.Follow through on our
Slogan
"Innovation today, healthier tomorrows" - We constantly pursue self-innovation to deliver innovative products and services with speed so that people around the world can lead healthier and more fulfilling lives.
- 2.Pursue trustworthy corporate activities.
-
We comply with laws and regulations, and conduct transparent and fair corporate activities with the
highest level of ethics.
We resolutely sever all relations with antisocial forces and organizations that present a threat to the order and security of civil society. - 3.Transparently disclose and properly manage information.
- We disclose corporate information in a timely and appropriate manner.
We take appropriate measures to protect and manage personal and customer information acquired through corporate activities. - 4.Improve individual capabilities and collaborate with peers.
-
We work together with respect for diversity, character and personality of peers in an effort to
create a healthy and safe work environment.
We focus on doing our best work as we strive for results in an organization that provides opportunities to grow and develop new skills. - 5.Respect human rights.
-
We respect the rights of all people associated with our company in conducting corporate
activities.
We seek ways to work with our business partners, including suppliers, and other relevant stakeholders to promote respect for human rights. - 6.Positively address global environmental issues.
- We engage in all aspects of our corporate activities in consideration of the environment.
- 7.Build harmonious relationships with society.
-
We value communications with all of our stakeholders and promote initiatives contributing to the
realization of a sustainable society.
We consider the local culture and customs of the countries and regions in which we operate, and contribute toward local economic and social development of those communities.

The Slogan reflects full commitment to deliver to society innovative products and healthcare solutions, created through groundbreaking ideas and high-standard research and development by each individual employee's challenge for innovation, so as to help enable the patients and their families lead healthier and fulfilling lives. It also expresses our Mission symbolically.
Strengths
Strengths
-
R&D Capabilities
Unique R&D capabilities in two priority disease areas and other areas
We are committed to contributing to the betterment of healthcare and fuller lives of people through a diverse range of approaches, including pharmaceuticals, regenerative medicine/cell therapy, and non-medical solutions, with a focus on the psychiatry & neurology area, and oncology area as its priority disease areas. We will also leverage our assets in other areas to deliver value to patients.


-
Human Resources
Human resources management that retains excellent talent and maximizes potential of each employee
Based on the corporate culture of diligence, integrity, and resilient and detailed execution, Sumitomo Pharma fosters professional human resources with CHANTO spirits, the capability to deliver the highest performance to achieve continuously creating and delivering innovation to people while transforming themselves in flexible ways to adapt to changes in the world, as the greatest driving force for delivering value.
A professional human resources system that harnesses human resources with a high ability to produce results based on their expertise
We have established a professional personnel system with the aim of building a strong corporate culture by maximizing the use of human resources who have enhanced their ability to produce results based on their expertise. In addition to the traditional career path of Professional Managers (PM), employees with a high ability to generate results as individuals based on their expertise are appointed as Professional Contributors (PC). We are promoting changes in the mindset of executives and younger employees to produce results both at the organization and the individual levels. We currently have about 40 people in PC positions.
Human resources with excellent research and development capabilities (technology, intelligence, and know-how)
We implement company-wide educational programs to enhance individual abilities and develop professional employees. In the case of R&D personnel with a high degree of specialization, we actively appoint young employees as project leaders to promote their professional growth.
Initiatives to further strengthen human resources
To foster future managers and executive candidates, we operate a selective education and training program called "SMP Academy," which promotes management literacy and strengthens problem-solving and strategy-formulation skills according to the ability stage of each participant. Further, we believe that it is important to provide equal opportunities for the active participation of diverse human resources, and we actively promote diversity and inclusion.
-
Foundation
We have a solid foundation including local headquarters functions, sales functions, and development functions in Japan, North America, China and Asia.
Since the merger, Sumitomo Pharma has strived to globalize its business. Currently, we have local headquarters, sales, and development functions in Japan, North America, and China & Asia, and are engaged in sales and marketing activities suited to each region, as well as expanding our business foundation with a focus on Asia.
Japan
In addition to the Psychiatry & Neurology Area, we are focusing on Diabetes and Rare Diseases Areas.
North America
Sumitomo Pharma America, Inc., which was integrated in July 2023 through the combination of the group companies conducts research and development, manufacturing, and sales of ethical pharmaceuticals.
Chinese mainland
Sumitomo Pharma (Suzhou) Co., Ltd. is engaged in manufacturing (subdivided packaging) and sales of pharmaceuticals. We operate our business in Infectious Disease Area and Psychiatry & Neurology Area.
Asia
Reinforce business functions in Singapore subsidiary and established Thailand, Malaysia, and Taiwan subsidiary
Europe and others
Collaboration with partners
Business Units
Business
Units

In order to deliver innovative and useful pharmaceuticals to people in Japan and around the world, we
devote all our efforts to R&D of new pharmaceuticals and providing information on pharmaceuticals with
the aim of improving customer satisfaction.
We also deploy frontier business with the aim of
providing new non-pharmaceutical healthcare solutions.
Vision
Vision


We have established its vision — For longer and healthier lives. We unlock the future with cutting-edge technology and ideas. We deliver innovative and differentiated pharmaceutical product and we also aim to establish ourselves as a "Global Specialized Player*" by 2033 by providing healthcare solutions that encompass the entire patient journey, including disease prevention, diagnosis, long-term care, and rehabilitation.
* Global Specialized Player: The Sumitomo Pharma Group is committed to contributing to the betterment of healthcare and fuller lives of people and to establishing its unique position worldwide through a diverse range of approaches, including pharmaceuticals, regenerative medicine/cell therapy, and non-pharmaceutical solutions, with a focus on the psychiatry & neurology area, and oncology area as its priority disease areas.